Page last updated: 2024-08-24

triazoles and C gattii Infection

triazoles has been researched along with C gattii Infection in 89 studies

Research

Studies (89)

Timeframe	Studies, this research(%)	All Research%
pre-1990	27 (30.34)	18.7374
1990's	12 (13.48)	18.2507
2000's	25 (28.09)	29.6817
2010's	22 (24.72)	24.3611
2020's	3 (3.37)	2.80

Authors

Authors	Studies
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M	1
Kakizaki, MIT; Melhem, MSC	1
Gandhi, TN; Linder, KA; Miceli, MH	1
Griener, TP; Grossman, J; Larios, O; Thornton, CS; Vaughan, S	1
Colom, MF; Cuetara, MS; Garcia-Benayas, E; Hagen, F; Jusdado Ruiz-Capillas, JJ; Nuñez-Valentin, MP; Rodríguez Garcia, E; Rodriguez-Gallego, JC; Rojo-Amigo, R	1
Bastos, RW; Carneiro, HCS; Carvalho, VSD; Costa, MC; Ferreira, GF; Freitas, GJC; Janbon, G; Magalhães, TFF; Moyrand, F; Oliveira, LVN; Paixão, TA; Rocha, CE; Rocha, KM; Santos, DA	1
Hatipoglu, H; Hatipoglu, N	1
Chowdhary, A; Espinel-Ingroff, A; Gonzalez, GM; Guinea, J; Hagen, F; Meis, JF; Thompson, GR; Turnidge, J	1
Bishop, R; Boris, L; Freeman, AF; Heller, T; Holland, SM; Jackson, MA; Kleiner, D; McGowan, K; Milligan, KL; Odio, CD; Rudman Spergel, AK; Urban, A; Welch, P	1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W	1
Azie, N; Cornely, OA; Engelhardt, M; Kovanda, L; Lee, M; Maher, R; Ostrosky-Zeichner, L; Perfect, JR; Queiroz-Telles, F; Rendon, A; Ribeiro Dos Santos, R; Thompson, GR; Vazquez, JA	1
Buil, JA; Díaz-Cascajosa, J; Roselló, N; Sanchez, F; Vela, JI	1
Boekhout, T; Bouza, E; Guinea, J; Hagen, F; Peláez, T; Tahoune, H; Torres-Narbona, M	1
Calvo, E; Guarro, J; Pastor, FJ; Pujol, I; Rodríguez, MM	1
Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG	1
Katragkou, A; Roilides, E; Tsikopoulou, F; Zaoutis, TE	1
Allada, G; Garrett, L; Marr, K; West, S	1
de Assis Baroni, F; Gambale, W; Paula, CR; Silva, EG	1
Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E	1
Allizond, V; Banche, G; Cuffini, AM; Fucale, G; Mandras, N; Roana, J; Scalas, D; Tullio, V	1
Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Thompson, GR; Wiederhold, NP	1
Bolden, CB; DeBess, EE; Harris, JR; Iqbal, N; Lockhart, SR; Marsden-Haug, N; Thakur, R; Worhle, R	1
Cleveland, KO; Gelfand, MS; Rao, V	1
Adachi, Y; Araki, K; Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Nagaoka, S; Wakabayashi, K; Yano, S	1
Costa, CR; de Fátima Lisboa Fernandes, O; de Paula, JA; de Souza Lino Junior, R; do Rosário Rodrigues Silva, M; Hasimoto E Souza, LK; Vinaud, MC	1
Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J	1
Fothergill, AW; Rinaldi, MG; Sutton, DA; Yildiran, ST	1
Arikan, U; Başaran, O; Emiroğlu, R; Haberal, M; Karakayali, H	1
Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M	1
Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH	1
Gil-Lamaignere, C; Müller, FM; Zhu, LP	1
Barchiesi, F; Carle, F; Giannini, D; Maracci, M; Scalise, G; Schimizzi, AM; Spreghini, E	1
Kofla, G; Ruhnke, M	1
Chen, R; Liao, W; Yao, Z	1
Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM	1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F	1
Aperis, G; Mylonakis, E	1
Casadevall, A; Mavrogiorgos, N; Nosanchuk, JD; Zaragoza, O	1
Aperis, G; Mylonakis, E; Spanakis, EK	1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C	1
Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF	1
Alvarado-Ramírez, E; Murciano, F; Sellart, M; Torres-Rodríguez, JM	1
Graybill, JR; Lewis, JS	1
Drutz, DJ; Graybill, JR; Kaster, SR	1
Plempel, M	1
Dismukes, WE	1
Craig, AJ; Love, DN; Malik, R; Martin, P; Wigney, DI	1
Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T	1
Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T	1
Kozel, TR; Lupan, DM; Manalo, PB; Roberts, JS; Savoy, AC; Schlageter, AM; Weinhold, LC	1
De Almeida, GM; Dodge, RK; Okonogi, K; Perfect, JR; Schell, WA	1
Hossain, MA; Kakeya, H; Kohno, S; Maesaki, S; Mitsutake, K; Sasaki, E; Tashiro, T; Tomono, K	1
Fukuoka, T; Habuki, S; Harasaki, T; Kamai, Y; Konosu, T; Nakamura, Y; Ohya, S; Oida, S; Somada, A; Tajima, Y; Tanaka, T; Yasuda, H	1
Arzeni, D; Barchiesi, F; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Fallani, S; Fortuna, M; Giacometti, A; Giannini, D; Mazzei, T; Novelli, A; Scalise, G; Schimizzi, AM	1
Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T	1
Ernst, EJ; Hoffman, HL; Klepser, ME	1
Barchiesi, F; Bocanegra, R; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Giacometti, A; Giannini, D; Graybill, JR; Najvar, LK; Scalise, G; Schimizzi, AM	1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A	1
Barchiesi, F; Camiletti, V; Caselli, F; Di Francesco, LF; Fileni, B; Giacometti, A; Giannini, D; Scalise, G; Schimizzi, AM	1
Bava, AJ; Negroni, R	1
Agorio, I; Costa, MR; Finquelievich, JL; Iovannitti, C; Loebenberg, D; Negroni, R; Tiraboschi, IN	1
Hector, RF; Yee, E	1
Perfect, JR; Ritter, W; Wright, KA	1
Ichise, K; Nakajima, T; Okuda, T; Tanio, T	1
Andriole, VT; Patterson, TF	1
Antinori, S; Esposito, R; Foppa, CU	1
Dietrich, D	1
Nakashima, M	1
Hanawa, T; Hatakenaka, R; Ikeda, S; Katsura, A; Kosaba, S; Lee, Y; Matsubara, Y; Ninomiya, K; Shiota, T; Yagi, K	1
Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M	1
Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T	1
Keil, TU	1
Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD	1
Knight, AG; Philpot, CM; Shuttleworth, D	1
Bordi, E; Galgani, S; Leoni, GC; Narciso, P; Sette, P; Tozzi, V; Visco, G	1
Ahrens, J; Graybill, JR; Restrepo, BI	1
Durack, DT; Hobbs, MM; Perfect, JR; Wright, KA	1
Collignon, P; Hurley, B; Mitchell, D	1
Polak, A	1
Arndt, CA; Balis, FM; McCully, CL; Pizzo, PA; Poplack, DG; Walsh, TJ	1
Byrne, WR; Wajszczuk, CP	1
de Graeff-Meeder, ER; Kuis, W; Paul, LC; van 't Wout, JW; van Furth, R	1
Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ	1
Saunders, C; Sugar, AM	1
Drouhet, E; Dupont, B	2
Durack, DT; Perfect, JR; Savani, DV	1
Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH	1
Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF	1

Reviews

11 review(s) available for triazoles and C gattii Infection

Article	Year
CRYPTOCOCCOSIS: A bibliographic narrative review on antifungal resistance. Anais da Academia Brasileira de Ciencias, 2023, Volume: 95, Issue:suppl 1 Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole	2023
Combination antifungal therapy for invasive fungal infections in children and adults. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole	2013
Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome. The Journal of allergy and clinical immunology, 2015, Volume: 136, Issue:5 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Coccidioides; Coccidioidomycosis; Colon; Cryptococcosis; Cryptococcus; Duodenal Ulcer; Endemic Diseases; Female; Histoplasma; Histoplasmosis; Humans; Itraconazole; Job Syndrome; Male; Middle Aged; Mutation; STAT3 Transcription Factor; Treatment Outcome; Triazoles; United States	2015
Posaconazole: when and how? The clinician's view. Mycoses, 2012, Volume: 55, Issue:2 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis, Invasive; Clinical Trials, Phase III as Topic; Cryptococcosis; Cryptococcus neoformans; Drug Administration Schedule; Drug Interactions; Humans; Microbial Sensitivity Tests; Triazoles	2012
Voriconazole: review of a broad spectrum triazole antifungal agent. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7 Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2005
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole	2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
Fungicidal versus Fungistatic: what's in a word? Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Cryptococcus; Echinocandins; Humans; Meningitis, Cryptococcal; Microbiological Techniques; Polyenes; Triazoles	2008
Management of cryptococcosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Meningitis; Triazoles	1993
Novel triazole antifungal agents. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles	2000
Current concepts in cryptococcosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Immune Tolerance; Prognosis; Triazoles; Virulence	1989

Trials

4 trial(s) available for triazoles and C gattii Infection

Article	Year
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2 Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole	2023
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 08-01, Volume: 63, Issue:3 Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Mycoses; Nitriles; Paracoccidioidomycosis; Pyridines; Triazoles; Young Adult	2016
[Clinical study of fluconazole on deep-seated fungal infections]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles	1989
Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. The American journal of medicine, 1988, Volume: 85, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Clinical Trials as Topic; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Triazoles	1988

Other Studies

74 other study(ies) available for triazoles and C gattii Infection

Article	Year
Treatment Failure of Isavuconazole in a Patient with Cryptococcosis. Mycopathologia, 2019, Volume: 184, Issue:5 Topics: Antifungal Agents; Cryptococcosis; Humans; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Middle Aged; Nitriles; Pyridines; Treatment Failure; Triazoles	2019
Pulmonary Cryptococcus infections as a manifestation of idiopathic CD4 lymphocytopenia: case report and literature review. BMC infectious diseases, 2019, Oct-17, Volume: 19, Issue:1 Topics: Antifungal Agents; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Female; Humans; Lung; Lymphopenia; Middle Aged; Respiratory Tract Infections; Thorax; Tomography, X-Ray Computed; Triazoles	2019
Successful Isavuconazole Salvage Therapy for a Cryptococcus deuterogattii (AFLP6/VGII) Disseminated Infection in a European Immunocompetent Patient. Mycopathologia, 2021, Volume: 186, Issue:4 Topics: Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Genotype; Humans; Nitriles; Pyridines; Salvage Therapy; Triazoles	2021
Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungicides, Industrial; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Triazoles; Virulence	2018
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2015
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina. Mycoses, 2016, Volume: 59, Issue:6 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Management of endogenous cryptococcal endophthalmitis with voriconazole. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:6 Topics: Aged, 80 and over; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Pyrimidines; Triazoles; Voriconazole	2009
Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain. Medical mycology, 2010, Volume: 48, Issue:7 Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Comorbidity; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; HIV Infections; Hospitals; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Serotyping; Spain; Triazoles	2010
Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Male; Mice; Pyrimidines; Triazoles; Voriconazole	2010
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans. Mycopathologia, 2011, Volume: 171, Issue:4 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts	2011
74-year-old man from the pacific northwest with fever and a lung mass. Chest, 2011, Volume: 140, Issue:3 Topics: Aged; Amphotericin B; Antifungal Agents; British Columbia; Bromhexine; Cryptococcosis; Cryptococcus gattii; Flucytosine; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Radiography; Triazoles	2011
Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID). Mycopathologia, 2012, Volume: 173, Issue:5-6 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Lung; Lung Diseases, Fungal; Mice; Mice, SCID; Pyrimidines; Severe Combined Immunodeficiency; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2012
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole	2012
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:6 Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Immunocompetence; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult	2011
A murine model of Cryptococcus gattii meningoencephalitis. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Animals; Antifungal Agents; Antigens, Fungal; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Histocytochemistry; Meningoencephalitis; Mice; Mice, Inbred ICR; Survival Analysis; Triazoles	2012
Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagnostic microbiology and infectious disease, 2012, Volume: 73, Issue:2 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Humans; Microbial Sensitivity Tests; Molecular Typing; Mycological Typing Techniques; Statistics, Nonparametric; Triazoles	2012
Posaconazole as successful treatment for fungemia due to Cryptococcus albidus in a liver transplant recipient. QJM : monthly journal of the Association of Physicians, 2013, Volume: 106, Issue:4 Topics: Antifungal Agents; Cryptococcosis; Fungemia; Humans; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Triazoles	2013
Sarcoid-like reaction in Cryptococcus neoformans infection. BMJ case reports, 2012, Jul-27, Volume: 2012 Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Radiography, Thoracic; Sarcoidosis; Triazoles; Voriconazole	2012
Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans. Mycopathologia, 2012, Volume: 174, Issue:5-6 Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fungal Capsules; Humans; Melanins; Microbial Sensitivity Tests; Pimenta; Plant Extracts; Pyrimidines; Triazoles; Voriconazole	2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole	2012
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592). Mycoses, 2002, Volume: 45, Issue:9-10 Topics: Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2002
Cryptococcal necrotizing fasciitis with multiple sites of involvement in the lower extremities. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:11 Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Cryptococcosis; Debridement; Fasciitis, Necrotizing; Humans; Immunocompromised Host; Kidney Transplantation; Leg; Male; Middle Aged; Skin Transplantation; Treatment Outcome; Triazoles	2003
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:6 Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole	2004
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole. Japanese journal of infectious diseases, 2004, Volume: 57, Issue:3 Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole	2004
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. Mycoses, 2004, Volume: 47, Issue:7 Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles	2004
Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Progression; Drug Therapy, Combination; Humans; Lung; Male; Mice; Survival Analysis; Triazoles	2004
Management of cryptococcosis in non-HIV-related patients. Medical mycology, 2005, Volume: 43, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles	2005
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole. Medical mycology, 2005, Volume: 43, Issue:6 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole	2005
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole	2006
Efficacy of voriconazole in experimental Cryptococcus neoformans infection. Mycopathologia, 2006, Volume: 162, Issue:2 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Lung Diseases, Fungal; Mice; Mice, Inbred C57BL; Polysaccharides; Pyrimidines; Triazoles; Voriconazole	2006
Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Animals; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Humans; Lung; Male; Mice; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2008
MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:1 Topics: Animals; Antifungal Agents; Bird Diseases; Columbidae; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole	2008
Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis. Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:6 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Triazoles	1983
Antimycotic activity of BAY N 7133 in animal experiments. The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5 Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles	1984
Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Australian veterinary journal, 1996, Volume: 73, Issue:4 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Injections, Subcutaneous; Male; Triazoles	1996
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles	1996
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles	1996
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis. Infection and immunity, 1997, Volume: 65, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Complex; Azepines; Chlorpheniramine; Chlorpromazine; Clodronic Acid; Complement System Proteins; Cryptococcosis; Dexamethasone; Elapid Venoms; Epinephrine; Female; Immunization, Passive; Immunoglobulin Isotypes; Kidney; Liver; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Polysaccharides; Shock; Specific Pathogen-Free Organisms; Triazoles; Tumor Necrosis Factor-alpha	1997
In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:10 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Microbial Sensitivity Tests; Rabbits; Triazoles	1998
In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:6 Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Humans; Lung; Lung Diseases, Fungal; Mice; Microbial Sensitivity Tests; Triazoles	1999
Synthesis and antifungal activities of R-102557 and related dioxane-triazole derivatives. Chemical & pharmaceutical bulletin, 2000, Volume: 48, Issue:5 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cryptococcosis; Cryptococcus neoformans; Dioxanes; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Rats; Rats, Inbred F344; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship; Triazoles	2000
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles	2000
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10 Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles	2000
Interactions of posaconazole and flucytosine against Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5 Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles	2001
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease. AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole	2001
Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6 Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Male; Mice; Microbial Sensitivity Tests; Triazoles	2001
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis. European journal of epidemiology, 1992, Volume: 8, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles	1992
Treatment of experimental cryptococcosis with SCH 39304 and fluconazole. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:7 Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Female; Fluconazole; Lung; Male; Rats; Rats, Inbred Strains; Triazoles	1991
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:3 Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles	1990
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis. The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:3 Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Rabbits; Triazoles	1990
In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6 Topics: Administration, Cutaneous; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis, Vulvovaginal; Cryptococcosis; Female; Fluconazole; Guinea Pigs; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Tinea; Triazoles	1990
Fluconazole for cryptococcal meningitis. Annals of internal medicine, 1989, Jan-15, Volume: 110, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Meningitis; Triazoles	1989
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug]. Fortschritte der Medizin, 1989, Mar-15, Volume: 107, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningitis; Opportunistic Infections; Prognosis; Triazoles	1989
[The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Fluconazole; Half-Life; Humans; Lung Diseases, Fungal; Male; Middle Aged; Triazoles	1989
[Clinical efficacy of fluconazole in the patient with pulmonary mycosis]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Female; Fever; Fluconazole; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Male; Middle Aged; Nausea; Triazoles	1989
[Clinical evaluation of fluconazole]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles	1989
[AIDS fungus infections. Fluconazole--a new preparation in development]. Fortschritte der Medizin, 1989, Mar-30, Volume: 107, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Opportunistic Infections; Triazoles	1989
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. Annals of internal medicine, 1989, Jul-15, Volume: 111, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Humans; Male; Meningitis; Prostatic Diseases; Recurrence; Triazoles; Urine	1989
Cutaneous cryptococcosis: treatment with oral fluconazole. The British journal of dermatology, 1989, Volume: 120, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Cryptococcosis; Dermatomycoses; Fluconazole; Humans; Male; Triazoles	1989
Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome. The American journal of medicine, 1989, Volume: 87, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Triazoles	1989
Efficacy of SCH39304 in murine cryptococcosis. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Female; Fluconazole; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Spleen; Triazoles	1989
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:10 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Meningitis; Microbial Sensitivity Tests; Rabbits; Triazoles	1989
Interaction of fluconazole with cyclosporin. Lancet (London, England), 1989, Jun-03, Volume: 1, Issue:8649 Topics: Creatinine; Cryptococcosis; Cyclosporins; Drug Interactions; Fluconazole; Humans; Kidney; Kidney Transplantation; Leg Dermatoses; Male; Middle Aged; Triazoles	1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy, 1987, Volume: 33, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles	1987
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. The Journal of infectious diseases, 1988, Volume: 157, Issue:1 Topics: Animals; Central Nervous System Diseases; Cryptococcosis; Fluconazole; Macaca mulatta; Male; Triazoles	1988
Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. Annals of internal medicine, 1988, Volume: 108, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles	1988
Treatment of two cases of cryptococcal meningitis with fluconazole. Scandinavian journal of infectious diseases, 1988, Volume: 20, Issue:2 Topics: Adolescent; Amphotericin B; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Triazoles	1988
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. The American journal of medicine, 1988, Volume: 85, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis; Middle Aged; Pneumonia; Triazoles	1988
Fluconazole for the treatment of fungal diseases in immunosuppressed patients. Annals of the New York Academy of Sciences, 1988, Volume: 544 Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Immunosuppression Therapy; Kidney Transplantation; Meningitis; Triazoles	1988
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:4 Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles	1986
Treatment of cryptococcal meningitis in mice with fluconazole. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Meningitis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Rats; Rats, Inbred Strains; Triazoles	1986
Cryptococcal meningitis and fluconazole. Annals of internal medicine, 1987, Volume: 106, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Meningitis; Triazoles	1987
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles	1987